Louis Staudt
New England Journal of Medicine · 2000–2022
A researcher in the Science corpus: 38 papers; trusts 0 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Who trusts Louis Staudt
- R. Lewis (in Molecular Biology)
- R. Dalla-Favera (in Immunology)
- M. Karin (in Cancer Research)
- M. Prakriya (in Physiology)
Papers from Louis Staudt's perspective
Ordered by how strongly the researchers Louis Staudt trusts endorse each paper. Same corpus, a different order for every researcher.
- Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma (Science)
- Wnt signaling and cancer. (Genes & Development)
- NF-κB Signals Induce the Expression of c-FLIP (Molecular and Cellular Biology)
- Inferring tumour purity and stromal and immune cell admixture from expression data (Nature Communications)
- A loss-of-function RNA interference screen for molecular targets in cancer (Nature)
- The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. (Blood)
- High-throughput oncogene mutation profiling in human cancer (Nature Genetics)
- Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB (Nature)
- Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase
- Genomic aberrations and survival in chronic lymphocytic leukemia. (New England Journal of Medicine)
Their papers
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (2000) — 10,272 citations
- 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns (2000) — 639 citations
- The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. (2003) — 970 citations
- A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma (2003) — 1,084 citations
- Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells (2001) — 1,153 citations
- IRF4 addiction in multiple myeloma (2008) — 706 citations
- The chromatin accessibility landscape of primary human cancers (2018) — 1,069 citations
- Gene regulation mediated by calcium signals in T lymphocytes (2001) — 620 citations
- Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia (2001) — 1,219 citations
- The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee. (2022) — 1,343 citations
- A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications (2020) — 974 citations
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma (2018) — 1,854 citations
- Toward a Shared Vision for Cancer Genomic Data (2016) — 1,463 citations
- Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma (2015) — 1,094 citations
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. (2014) — 705 citations
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer (2013) — 827 citations
- Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics (2012) — 975 citations
- Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. (2012) — 1,068 citations
- MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers (2011) — 612 citations
- Chronic Active B Cell Receptor Signaling in Diffuse Large B Cell Lymphoma (2010) — 1,639 citations